Skip to content
MS
Single-pathway Pathway metabolite unreviewed

LTB4, or LTA4

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving LTB4, or LTA4

Every recorded step where this molecule takes part

Showing all 1 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Lipoxygenase (LOX) signaling in epilepsy: Pathophysiology and therapeutic prospects.

    Rakib MA, Yu Y, Jiang J. · 2026-06-22

    open access unreviewed
  2. 2
    Beyond Hemostasis: Platelets' Multifaceted Functions in Immune Responses.

    Doolittle WKL, Walters EL, Maitta RW. · 2026-07-21

    open access unreviewed
  3. 3
    Lipid Mediators in Host-Pathogen Interactions during <i>Leishmania</i> Infection: Friends or Foes?

    Andrade YMFS, Silva DA, Nascimento TLP, Sousa MO, Carvalho BLA, Lima JB, Borges VM, Araújo-Santos T. · 2026-05-25

    cited 1× open access unreviewed
  4. 4
    Disturbed LTB4 Metabolism in ILC2s Aggravates Ulcerative Colitis via Intercellular ATP Accumulation.

    Li W, Zheng M, Wang Y, Chen Y, Bai H, Li R, Li S, Li Y. · 2026-03-16

    open access unreviewed
  5. 5
  6. 6
    Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis.

    Ma Y, Jiang J, Zhao C, Wei B, Gao J. · 2025-08-29

    cited 11× open access unreviewed
  7. 7
    Roles of Lipoxygenases in Cardiovascular Diseases.

    Liu T, Ai D. · 2025-03-25

    cited 7× open access unreviewed
  8. 8
    Neutrophil recruitment depends on platelet-derived leukotriene B4.

    Hackenbroch C, Cimen T, Gross C, Rubenzucker S, Burkard P, Groß N, Ahrends R, Girbl T, Stegner D. · 2025-05-01

    cited 5× open access unreviewed
  9. 9
    Arachidonic acid in aging: New roles for old players.

    Qian C, Wang Q, Qiao Y, Xu Z, Zhang L, Xiao H, Lin Z, Wu M, Xia W, Yang H, Bai J, Geng D. · 2024-05-04

    cited 30× open access unreviewed
  10. 10
    Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias.

    Bahrami P, Aromolaran KA, Aromolaran AS. · 2025-02-01

    cited 5× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.